MICROBIAL-METABOLISM OF PHENELZINE AND PHENIPRAZINE

被引：17

作者：

FOSTER, BC

COUTTS, RT

PASUTTO, FM

MOZAYANI, A

机构：

[1] UNIV ALBERTA,FAC PHARM & PHARMACEUT SCI,EDMONTON T6G 2N8,ALBERTA,CANADA

[2] HLTH & WELF CANADA,DIV PHARMACEUT CHEM,TUNNEYS PASTURE,OTTAWA K1A 0L2,ONTARIO,CANADA

来源：

LIFE SCIENCES | 1988年 / 42卷 / 03期

关键词：

D O I：

10.1016/0024-3205(88)90637-6

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：285 / 292

页数：8

共 29 条

[1]

ANDERSON FE, 1962, J MED CHEM, V5, P221, DOI 10.1021/jm01237a001

[2]

BECKETT AH, 1978, DRUG METABOLISM MAN, P237

[3]

BOULTON AA, 1975, 21ST P CAN SPEC C, P40

[4] URINARY-EXCRETION OF PHENELZINE [J].

CADDY, B ;

STEAD, AH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (02) :185-188

[5] PHENELZINE IN URINE - ASSAY AND RELATION TO ACETYLATOR STATUS [J].

CADDY, B ;

TILSTONE, WJ ;

JOHNSTONE, EC .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (04) :633-637

[6] THE USE OF MICROORGANISMS FOR THE STUDY OF DRUG-METABOLISM [J].

CLARK, AM ;

MCCHESNEY, JD ;

HUFFORD, CD .

MEDICINAL RESEARCH REVIEWS, 1985, 5 (02) :231-253

[7] MONOAMINE OXIDASE CATALYZED DEGRADATION OF PHENELZINE-1-14C AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE .2. [J].

CLINESCHMIDT, BV ;

HORITA, A .

BIOCHEMICAL PHARMACOLOGY, 1969, 18 (05) :1021-+

[8]

CLINESCHMIDT BV, 1969, BIOCHEM PHARMACOL, V18, P1011, DOI 10.1016/0006-2952(69)90104-X

[9]

CLINESCHMIDT V, 1967, BRIT J PHARM CHEMOTH, V30, P67

[10] METABOLIC FATE OF HYDRAZINES AND HYDRAZIDES [J].

COLVIN, LB .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (12) :1433-&

← 1 2 3 →